相关实验视频

Updated: Jan 18, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

撒哈拉以南非洲囚犯中MDR-TB的负担和决定因素:系统审查和元分析协议

Doris Y Sakala¹, Jacques M Tamuzi¹, Constance S Shumba²

¹Division of Epidemiology and Biostatistics, Faculty of Medicine & Health Sciences, Stellenbosch University, Cape Town, South Africa.

Journal of public health in Africa

|September 12, 2025

概括

本系统性审查调查了撒哈拉以南非洲监狱中的多抗药结核病 (MDR-TB). 它旨在了解这一脆弱人群中MDR-TB的患病率和治疗结果,以告知公共卫生指南.

科学领域:

公共卫生公共卫生
传染性疾病传染性疾病
流行病学流行病学

背景情况:

结核病 (TB) 仍然是全球主要的死亡原因.
多药耐药结核病 (MDR-TB) 由于成本增加和治疗持续时间增加,给卫生系统带来了重大挑战.
监狱人口不成比例地受到结核病的影响,并面临较差的治疗结果,增加了他们对MDR-TB的脆弱性.

研究的目的:

系统地审查和对撒哈拉以南非洲 (SSA) 囚犯中MDR-TB的负担进行元分析.
在这一群体中调查MDR-TB的相关因素和治疗结果.
为制定有针对性的公共卫生干预和指导方针提供证据.

主要方法:

按照PRISMA指南进行系统审查和元分析.
在数据库 (Medline,Embase,CINAHL,Scopus,Web of Science) 搜索了2000年至2024年期间在南非监狱中对MDR-TB的研究.
使用元分析技术分析连续和二进制结果,用I平方统计评估异质性,并在必要时使用随机效应模型. 用于风险因素识别的元回归.

主要成果:

监狱中MDR-TB的综合流行率将以比例呈现.
分析结果,包括赔率比率和置信区间,将使用森林地块进行可视化.
研究结果的叙述综合将以表格形式提供.

结论:

这次审查将巩固有关MDR-TB负担和SSA监狱的结果的证据.
调查结果将有助于制定基于证据的公共卫生指南,用于查,诊断和管理.
这项研究旨在减少MDR-TB的传播,并提高惩戒设施的治疗成功率.

关键词:

监狱是指惩教设施.广泛的耐药性结核病.抗药性结核病多种药物的结核病.监狱监狱监狱监狱撒哈拉以南非洲地区.

更多相关视频

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...